BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 19735549)

  • 1. An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ.
    Behbod F; Kittrell FS; LaMarca H; Edwards D; Kerbawy S; Heestand JC; Young E; Mukhopadhyay P; Yeh HW; Allred DC; Hu M; Polyak K; Rosen JM; Medina D
    Breast Cancer Res; 2009; 11(5):R66. PubMed ID: 19735549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
    Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V
    Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model.
    Valdez KE; Fan F; Smith W; Allred DC; Medina D; Behbod F
    J Pathol; 2011 Dec; 225(4):565-73. PubMed ID: 22025213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse Mammary Intraductal (MIND) Method for Transplantation of Patient Derived Primary DCIS Cells and Cell Lines.
    Kittrell F; Valdez K; Elsarraj H; Hong Y; Medina D; Behbod F
    Bio Protoc; 2016 Mar; 6(5):. PubMed ID: 27446983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s).
    Scribner KC; Behbod F; Porter WW
    Oncogene; 2013 May; 32(21):2631-9. PubMed ID: 22777354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse-INtraDuctal (MIND): an in vivo model for studying the underlying mechanisms of DCIS malignancy.
    Hong Y; Limback D; Elsarraj HS; Harper H; Haines H; Hansford H; Ricci M; Kaufman C; Wedlock E; Xu M; Zhang J; May L; Cusick T; Inciardi M; Redick M; Gatewood J; Winblad O; Aripoli A; Huppe A; Balanoff C; Wagner JL; Amin AL; Larson KE; Ricci L; Tawfik O; Razek H; Meierotto RO; Madan R; Godwin AK; Thompson J; Hilsenbeck SG; Futreal A; Thompson A; Hwang ES; Fan F; Behbod F;
    J Pathol; 2022 Feb; 256(2):186-201. PubMed ID: 34714554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression.
    Kim HS; Jung M; Choi SK; Woo J; Piao YJ; Hwang EH; Kim H; Kim SJ; Moon WK
    J Exp Clin Cancer Res; 2018 Aug; 37(1):200. PubMed ID: 30134951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.
    Shekhar MP; Tait L; Pauley RJ; Wu GS; Santner SJ; Nangia-Makker P; Shekhar V; Nassar H; Visscher DW; Heppner GH; Miller FR
    Cancer Biol Ther; 2008 Nov; 7(11):1774-82. PubMed ID: 18787417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.
    Russell TD; Jindal S; Agunbiade S; Gao D; Troxell M; Borges VF; Schedin P
    Am J Pathol; 2015 Nov; 185(11):3076-89. PubMed ID: 26343330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
    Tsang WY; Chan JK
    Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma.
    Moriya T; Silverberg SG
    Cancer; 1994 Dec; 74(11):2972-8. PubMed ID: 7954261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human 21T breast epithelial cell lines mimic breast cancer progression in vivo and in vitro and show stage-specific gene expression patterns.
    Souter LH; Andrews JD; Zhang G; Cook AC; Postenka CO; Al-Katib W; Leong HS; Rodenhiser DI; Chambers AF; Tuck AB
    Lab Invest; 2010 Aug; 90(8):1247-58. PubMed ID: 20458274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog.
    Wahler J; So JY; Kim YC; Liu F; Maehr H; Uskokovic M; Suh N
    Cancer Prev Res (Phila); 2014 Jun; 7(6):617-26. PubMed ID: 24691501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
    Elsarraj HS; Hong Y; Valdez KE; Michaels W; Hook M; Smith WP; Chien J; Herschkowitz JI; Troester MA; Beck M; Inciardi M; Gatewood J; May L; Cusick T; McGinness M; Ricci L; Fan F; Tawfik O; Marks JR; Knapp JR; Yeh HW; Thomas P; Carrasco DR; Fields TA; Godwin AK; Behbod F
    Breast Cancer Res; 2015 Sep; 17():128. PubMed ID: 26384318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraductal Injections into the Mouse Mammary Gland.
    Oliemuller E; Newman R; Howard BA
    Methods Mol Biol; 2022; 2471():221-233. PubMed ID: 35175600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
    Soon PS; Provan PJ; Kim E; Pathmanathan N; Graham D; Clarke CL; Balleine RL
    Clin Exp Metastasis; 2018 Feb; 35(1-2):3-13. PubMed ID: 29214365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of ductal carcinoma in situ with nipple discharge. Intraductal spreading of carcinoma is an unfavorable pathologic factor for breast-conserving surgery.
    Ohuchi N; Furuta A; Mori S
    Cancer; 1994 Aug; 74(4):1294-302. PubMed ID: 8055451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer subtype-specific interactions with the microenvironment dictate mechanisms of invasion.
    Dang TT; Prechtl AM; Pearson GW
    Cancer Res; 2011 Nov; 71(21):6857-66. PubMed ID: 21908556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoma arising from preexisting pregnancy-like and cystic hypersecretory hyperplasia lesions of the breast: a clinicopathologic study of 9 patients.
    Shin SJ; Rosen PP
    Am J Surg Pathol; 2004 Jun; 28(6):789-93. PubMed ID: 15166671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.